Glutamate system is modified by ethanol and contributes both to the euphoric and the dysphoric consequences of intoxication, but there is now growing evidence that the glutamatergic system also plays a central role in the neurobiology and treatment of mood disorders, including major depressive disorders and bipolar disorders.We speculate that, using acamprosate, patients with bipolar depression (BIP-A) can take advantage of the anti-glutamate effect of acamprosate to “survive” in treatment longer than peers suffering from non-bipolar depression (NBIP-A) after detoxification.
Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study
MAREMMANI, ANGELO GIOVANNI ICRO;BACCIARDI, SILVIA;ROVAI, LUCA;MASSIMETTI, ENRICO;GAZZARRINI, DENISE;DELL'OSSO, LILIANA;MAREMMANI, ICRO
2014-01-01
Abstract
Glutamate system is modified by ethanol and contributes both to the euphoric and the dysphoric consequences of intoxication, but there is now growing evidence that the glutamatergic system also plays a central role in the neurobiology and treatment of mood disorders, including major depressive disorders and bipolar disorders.We speculate that, using acamprosate, patients with bipolar depression (BIP-A) can take advantage of the anti-glutamate effect of acamprosate to “survive” in treatment longer than peers suffering from non-bipolar depression (NBIP-A) after detoxification.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
DellOsso_800469.pdf
accesso aperto
Tipologia:
Versione finale editoriale
Licenza:
Creative commons
Dimensione
678.6 kB
Formato
Adobe PDF
|
678.6 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.